3D bio-printer developed by Japanese venture firm

TOKYO, Japan - A three-dimensional bio-printer developed by Cyfuse Biomedical K.K. is shown in Kyoto, western Japan, on March 5, 2014. The minute tubule at the center of the printer absorbs a block of cells and sticks it through one of needles on the pinholder-like device below. Cell aggregates thus produced are used for tissue fabrication such as for creating blood vessels.

Sample
PDF Preview

Product Code
ILEA001195719

Registered date
2014/3/05 00:00:00

Credit
Kyodo / Kyodo News Images

Media source
2014 Kyodo News

Media size
1868 × 2400 pixel

Resolution
240 dpi

Deployment size
472.07(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

Purported "STAP cells" likely came from embryonic stem cells

TOKYO, Japan - Haruko Obokata, then a researcher with the Riken research institute, announces the creation of the "STAP cells," claimed to be capable of developing into any type of tissue, in Kobe, western Japan, in this file photo taken in January 2014. A panel under the government-backed institute said Dec. 26, 2014, that the STAP cells that Obokata claimed to have created were likely cells generated from embryonic stem cells. Obokata left her job at Riken on Dec. 21.

Gunze aims to commercialize regenerative blood vessels

AYABE, Japan - Masakazu Suzuki, director of Gunze Ltd.'s quality of life research center, shows a tube for producing fiber-engineered blood vessels during a press tour of the facility in Ayabe, Kyoto Prefecture, western Japan, on Dec. 3, 2014. The apparel company aims to commercialize the world's first regenerative blood vessels in the United States by 2016.

World's 1st iPS cell transplant

OSAKA, Japan - Masayo Takahashi (L), project leader at Riken Center for Developmental Biology, inspects an experiment at Riken's stem cell culture laboratory in Kobe, western Japan, in February 2013. A Japanese team has recently conducted the world's first surgery to implant tissue derived from induced pluripotent stem cells into a human body as part of the clinical study led by Takahashi and others.

Indian leader Modi meets Nobel laureate Yamanaka in Kyoto

KYOTO, Japan - Indian Prime Minister Narendra Modi (R) shakes hands with Nobel Prize laureate Shinya Yamanaka, professor and head of Kyoto University's Center for iPS Cell Research and Application, at the center in Kyoto, western Japan, on Aug. 31, 2014. Modi is said to be keen in promoting stem cell research in India as it may lead to finding an effective treatment for people suffering from blood diseases.

STAP cells paper co-author Sasai commits suicide

KOBE, Japan - Riken staff are surrounded by reporters on Aug. 5, 2014, in the western Japan city of Kobe, following the suicide of Yoshiki Sasai, deputy director of the Riken Center for Developmental Biology and a co-author of controversial research papers on so-called STAP cells.

Obokata agrees to retract primary STAP cell paper

TOKYO, Japan - In this file photo taken in Kobe in western Japan on Jan. 28, 2014, Japanese scientist Haruko Obokata briefs reporters on the production of so-called STAP cells capable of developing into any type of tissue. The government-backed Riken institute said on June 4, 2014, that Obokata has agreed to retract a key paper claiming STAP cell production and deliver the agreed document to co-authors of the paper.

Riken admits malpractice in STAP papers

TOKYO, Japan - Ryoji Noyori (2nd from R), Nobel Prize laureate and president of the government-affiliated Riken institute, speaks at a press conference in Tokyo on March 14, 2014, to provide an interim report on the institute's investigation into allegations concerning two recent papers on potentially groundbreaking stem cell research. Riken admitted that the papers on so-called STAP cells show aspects of serious malpractice.

STAP cell research paper questioned

TOKYO, Japan - File photo taken in January 2014 in Kobe, Hyogo Prefecture, shows Haruko Obokata (L), a scientist at the Riken Center for Developmental Biology, and University of Yamanashi professor Teruhiko Wakayama, at a press conference on "stimulus-triggered acquisition of pluripotency," or STAP, a method of generating pluripotent cells. Wakayama said March 10, 2014, he has told his co-authors including Obokata that their research paper on STAP cells should be retracted, citing the lack of credibility of some data used in the research.

Stem cell research paper questioned

KOFU, Japan - University of Yamanashi professor Teruhiko Wakayama meets reporters in Kofu, Yamanashi Prefecture, on March 10, 2014. Wakayama has told his co-authors that their research paper on what appeared to be a groundbreaking method for producing stem cells should be retracted and resubmitted. Questions have been raised about irregular images contained in the paper, written by a group led by Haruko Obotaka at the Center for Developmental Biology of the government-affiliated Riken institute, on a method it named "stimulus-triggered acquisition of pluripotency" or STAP.

Japan scientist proposes to retract stem cell research paper

KOFU, Japan - Teruhiko Wakayama, a professor at the University of Yamanashi and one of the co-authors of a research paper on what appeared to be a groundbreaking method of producing stem cells, explains his proposal to retract the paper in Kofu, Yamanashi Prefecture, central Japan, on March 10, 2014. Questions have been raised about irregular images contained in the paper, written by a group led by Haruko Obotaka at the Center for Developmental Biology of the government-run Riken institute, on a method it named "stimulus-triggered acquisition of pluripotency" or STAP.